Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase(R) and hypothesis on the underlying mechanism.

HOME
>
論文・技術情報
>
Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase(R) and hypothesis on the underlying mechanism.

アブストラクト
ジャーナル名	European journal of clinical pharmacology
Pubmed追加日	2020/5/4
投稿者	Delafoy, Clemence; Dolladille, Charles; Besnier, Paul; Sassier, Marion; Bourgine, Joanna; Lelong-Boulouard, Veronique; Alexandre, Joachim; Guillaume, Cyril; Fedrizzi, Sophie; Chretien, Basile
組織名	Department of Pharmacology, Caen University Hospital, F-14000, Caen, France.;Pharmacovigilance Regional Center, Caen University Hospital, F-14000, Caen,;France.;Signalisation, Electrophysiologie et Imagerie des Lesions d'Ischemie-Reperfusion;Myocardique, Normandie University, UNICAEN, Caen University Hospital, 14000,;Caen, France.;COMETE-MOBILITES << Vieillissement, pathologie, sante >>, Normandie Univ,;UNICAEN, UFR Sante, INSERM UMR 1075, 14032, Caen, France.;Department of Pain and Palliative care, Caen University Hospital, F-14000, Caen,;chretien-b@chu-caen.fr.;France. chretien-b@chu-caen.fr.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/32361903/